Predictive role of endothelial cell activation in cytokine release syndrome after chimeric antigen receptor T cell therapy for acute lymphoblastic leukaemia

CD19‐target chimeric antigen receptor (CAR)‐T cell therapy is highly effective for relapsed/refractory (R/R) acute lymphoblastic leukaemia (ALL), but is often complicated by cytokine release syndrome (CRS), which is potentially life‐threatening. Endothelial cells are the core regulator of CRS in man...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Fei, Shi, Ming, Cao, Jiang, Wang, Ying, Gong, Yanqing, Gao, Hui, Li, Zhenyu, Zheng, Junnian, Zeng, Lingyu, He, Aili, Xu, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650023/
https://www.ncbi.nlm.nih.gov/pubmed/34734474
http://dx.doi.org/10.1111/jcmm.17029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650023/
https://www.ncbi.nlm.nih.gov/pubmed/34734474
http://dx.doi.org/10.1111/jcmm.17029

Ejemplares similares